| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 04/16/2008 | EP1909790A1 Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation |
| 04/16/2008 | EP1909781A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 04/16/2008 | EP1909769A2 Alcohol resistant pharmaceutical formulations |
| 04/16/2008 | EP1909764A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 04/16/2008 | EP1909600A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1349559B1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 04/16/2008 | EP1309613B1 Pharmaceutical composition comprising an analgesic peptide |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163715A A therapeutic agent for ass related disorders |
| 04/16/2008 | CN101163689A Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| 04/16/2008 | CN101163678A 吡啶基甲基砜衍生物 Pyridyl methyl sulfone derivative |
| 04/16/2008 | CN101163477A Multimediator dopamine transport inhibitors, and uses related thereto |
| 04/16/2008 | CN101163466A Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-l,3- cyclohexanedione in the treatment of parkinson's disease |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161282A Blood circulation promoting nourishing kidney health preserving electric girdle |
| 04/16/2008 | CN101161280A Medicine for curing epilepsy |
| 04/16/2008 | CN101161271A Eight delicacies easy gloomy chinese medicine composition |
| 04/16/2008 | CN101161245A Purpose of toluylene glycosides and its derivant for restraining synapse ribonucleoprtein excess expression |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381446C Aminomethyl-substituted thiazolobenzimidazole derivative |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/16/2008 | CN100381168C Use of glucoprotein for pharmaceuticals |
| 04/16/2008 | CN100381167C Medicine for treating neurasthenia |
| 04/16/2008 | CN100381165C Medication for improving sleep |
| 04/16/2008 | CA2683910A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358264 Statine derivatives for the treatment of Alzheimer's disease |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358258 Prodrugs of an ERK protein kinase inhibitor |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7358235 Nitrobenzylthioinosine compounds for relief of pain |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7357934 Intracranial botulinum toxin therapy for focal epilepsy |
| 04/15/2008 | CA2381797C Composition comprising a tramadol material and an anticonvulsant drug |
| 04/15/2008 | CA2360246C Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 04/15/2008 | CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein |
| 04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
| 04/15/2008 | CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect |
| 04/13/2008 | CA2606658A1 Compositions and methods for treating neurological disorders or damage |
| 04/10/2008 | WO2008042735A1 Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines |
| 04/10/2008 | WO2008042388A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | WO2008042174A2 Mesenchymal stem cells and uses therefor |
| 04/10/2008 | WO2008041075A1 Mglur5 modulators |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2008040935A1 New polymorphic forms of pregabalin |
| 04/10/2008 | WO2008040816A1 Amorphous asenapine and processes for preparing same |
| 04/10/2008 | WO2008040560A1 Process for the preparation of memantine and its hydrochloric acid salt form |
| 04/10/2008 | WO2008040481A1 MIXED ORL 1/μ AGONISTS FOR TREATING PAIN |
| 04/10/2008 | WO2008040332A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 04/10/2008 | WO2008040260A1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 04/10/2008 | WO2008040153A1 Application of a coumarin compound in preparation of medicament for inducing nerve stem cell orienting differentiation |
| 04/10/2008 | WO2008017752A3 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 04/10/2008 | WO2008010222A3 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders |
| 04/10/2008 | WO2008007131A3 Treatment for demyelinating disease |
| 04/10/2008 | WO2008003780A3 Use of proteins of the sdf-1-family for improvement of axonal plasticity or for axonal regeneration following lesions |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007146115A3 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 04/10/2008 | WO2007129221A8 Compositions comprising an epi-inositol compounds and methods for treatment of disorders of protein aggregation |
| 04/10/2008 | WO2007092469A3 Combination of organic compounds |
| 04/10/2008 | WO2006096405A8 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 04/10/2008 | WO2006065968A3 The uses of estrogen beta agonists to treat cognitive diseases |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085938 Arylamino-Arylpropanolamine Derivatives and Methods of Their Use |
| 04/10/2008 | US20080085932 Pharmaceutical Compositions Useful In Prevention and Treatment of Beta-Amyloid Protein-Induced Disease |
| 04/10/2008 | US20080085930 Characterized by a powder X-ray diffraction pattern having one powder X-ray diffraction peak at about 10.0 degrees 2-theta; useful for treating and/or preventing central nervous system disorders such as epilepsy, stroke, muscle spasms, neuropathic pain, and migraine |
| 04/10/2008 | US20080085925 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 04/10/2008 | US20080085923 Thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer; use with other drugs such as aspirin, clodipogrel, prasugrel, cangrelor, Fragmin; himbacine derivatives |
| 04/10/2008 | US20080085920 Composition comprising N-butyl-1-deoxy-nojirimycin, D-glucaro-delta-lactam, and N-ethyl-1-dexynojirimycin in a pharmaceutically acceptable carrier; treatment of chronic pain and neurodegeneration, neuropathic pain, visceral pain, fibromyalgia pain, inflammatory pain, headache pain, muscle pain |
| 04/10/2008 | US20080085913 Polymorphic Forms of a Gabaa Agonist |
| 04/10/2008 | US20080085901 Heteroaryl Substituted Quinolin-4-Ylamine Analogues |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
| 04/10/2008 | US20080085896 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085889 Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them |
| 04/10/2008 | US20080085888 Synergistic combination of antipsychotic agent and a second therapeutic agent, which is (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, for treating psychiatric disorders, particularly, cognitive impairment disorders |
| 04/10/2008 | US20080085885 Selective melanocortin-4 receptor agonist, dose dependently reducing ethanol self administration; alcoholism, alcohol abuse |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085317 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions |
| 04/10/2008 | US20080085306 Topiramate compositions and methods of enhancing its bioavailability |